Incyte(INCY) - 2024 Q1 - Quarterly Results

Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs Conference Call and Webcast Scheduled Today at 8:00 a.m. ET WILMINGTON, Del. – April 30, 2024 – Incyte (Nasdaq:INCY) today reports 2024 first quarter financial results, and provides a status update on the Company's clinical development portfolio. Exhibit 99.1 FOR IMMEDIATE RELEASE "In the first quarter of 2024, total revenues grew 9% year-over-year driven by patient demand growth in the U.S. for Opzelura® (ruxo ...